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ABSTRACT
Fish have become a popular experimental model and companion animal, and are also farmed and caught
for food. Thus, surgical and invasive procedures in this animal group are common, and this review will
focus on the anesthesia and analgesia of fish. A variety of anesthetic agents are commonly applied to fish
via immersion. Correct dosing can result in effective anesthesia for acute procedures as well as loss of
consciousness for surgical interventions. Dose and anesthetic agent vary between species of fish and are
further confounded by a variety of physiological parameters (e.g., body weight, physiological stress) as
well as environmental conditions (e.g., water temperature). Combination anesthesia, where 2 anesthetic
agents are used, has been effective for fish but is not routinely used because of a lack of experimental
validation. Analgesia is a relatively underexplored issue in regards to fish medicine. However, recent
studies have investigated opioid agents, nonsteroidal anti-inflammatory drugs, and local anesthetics to
determine their efficacy in minimizing pain and discomfort. The opioid morphine and the local anesthetic
lidocaine do have significant effectiveness in reducing pain-related responses in rainbow trout
(Oncorhynchus mykiss). Studies aimed at developing reliable analgesic protocols should explore a wide
range of analgesic drug classes in several fish species.

Recent research studies have suggested that fish are capable of nociception or pain perception. These
investigations have demonstrated that bony (teleost) fish have nociceptors, receptors to detect potentially
painful stimuli (Fig 1), which are very similar to those found in mammals.1-6 A variety of species also
7-12
exhibit adverse behavioral and physiological responses to a potentially painful event
that are
13,14
ameliorated by the use of analgesia (Fig 2).
Therefore, it would seem prudent to reduce any pain and
discomfort during surgical interventions or when tissue damage has or is likely to occur. Anesthetic drugs
15
have historically been used on fish in aquaculture, experimentation, and veterinary practice. Their use
reduces the stressful impacts of handling, especially during routine procedures such as weighing,
vaccination, blood sampling, tagging, experimental surgery, and veterinary procedures. Therefore, light
anesthesia or sedation can improve the efficiency of rapid procedures. In invasive procedures in which
tissue damage will occur, full or deep anesthesia or loss of consciousness is used to improve fish welfare
16-19
and minimize the pain associated with surgical intervention.
Anesthetic administration is usually
achieved via immersion, with the drug being dissolved in water where the fish is held or an anesthetic
vessel such as a tank or large bucket (also termed inhalation). When induction takes place through
immersion, it is paramount to observe the fish and gauge the depth of anesthesia to reduce the incidence

of overdose. Uptake of these chemicals is primarily via the gills and possibly the skin. The level of
anesthesia is monitored by recording gill ventilation rates, maintenance of equilibrium (upright position),
and reflex responses (e.g., swimming response to tail pinch). Research studies have measured rates of
induction and recovery, responsiveness to external stimuli and handling, as well as pharmacokinetics of
these agents. However, these research investigations often focus on a small range of species, testing
only one anesthetic agent or a range of drugs on one species.
5

Analgesia has received much less attention, especially before 2003 ; historically, fish were thought to be
20
incapable of nociception or pain. However, studies are now trying to show the efficacy of analgesic
medication in reducing or ameliorating any detrimental changes in behavior and physiology as a result of
damage or noxious stimulation. This article will focus on what is known regarding anesthesia (primarily
immersion) and analgesia in fish to provide an up-to-date account that can be referred to by scientists
and veterinarians. Using the most efficient means of reducing stress and/or pain is crucial for the welfare
of animals treated.
ANESTHESIA IN FISH
As with most other animals, induction and the depth of anesthesia in fish are generally divided into
increasing stages or planes (Table 1). Monitoring of activity or swimming, posture, behavior, gill
ventilation rate, eye movement, reflex responses, and heart rate is commonly done for fish; the degree of
change desired will be dependent on the level of anesthesia required for a particular procedure. If
induction is rapid, one can have difficulty differentiating one stage from another; therefore, use of the
correct dose is particularly important to avoid overdose. For rapid and noninvasive procedures, light
anesthesia can be sufficient (e.g., weighing, handling, inspection, gill scrape, external tagging). However,
for invasive procedures and those of longer duration, surgical anesthesia is advised and may need to be
accompanied by artificial ventilation of gills by flushing fresh or anesthetic-dosed water with a mouthpiece
and pump when necessary. It is particularly important that the water is aerated and maintained at a
similar temperature as its normal environment to avoid unnecessary stress to these poikilotherms.
21
Hypoxia can elicit a stress response in fish, which may impede recovery after anesthesia. A hypoxic
state can also occur if the gills are not fully irrigated, causing gill filaments to collapse and become
ischemic. Indeed, all water-quality parameters should be identical to the fish’s normal tank water (e.g.,
pH, salinity, hardness), and ideally the water used for anesthesia should be obtained from the home tank
or aquarium system to reduce stress. Other factors such as temperature, body weight, and fish condition
influence a fish’s response to anesthesia.
TYPES OF ANESTHETIC AGENTS
A range of anesthetic agents are currently in use in laboratory, veterinary, and aquaculture contexts. The
most common anesthetic drugs used in fish are MS-222 (Tricaine), benzocaine, isoeugenol, metomidate,
16-19
2-phenoxyethanol, and quinaldine.
Experimental studies have explored the induction, recovery rate,
and pharmocokinetics as well as undesirable or adverse side effects. However, these research
investigations are limited to a relatively small number of species and caution should be applied when
using any of these agents on a nonvalidated species. Fish are incredibly diverse, and a shift in water
quality and environmental requirements can significantly influence the efficacy of an anesthetic agent.
Therefore, low doses should be used initially with incremental increases until the most effective dose is
achieved (Table 2). Although this review focuses on immersion anesthesia, injectable anesthetics are
17
fairly common in larger species of fish.

FIGURE 1. (A) Nerves in the tailfin of common carp (Cyprinus carpio) (x200). 1: nerve bundle, 2: blood vessel, 3:
lepidotrichial hemisegment. (B) Detail from the red box in (A) shows a transverse section of the interior of the
lepidotrichia segment of the tailray showing 2 nerves (EM, scale bar=5µm). (C) Nerve fibers in tailfin of common carp
(TEM, scale bar=500 nm). Both C-fibers (1) and 3 categories of A-fibers (2) are present within the nerve. Schwann
cell (3) producing the myelin sheets around A-fibers. Black spots in the neurite neuroplasm represent microtubules.
6
C-fibers and A-fibers act as nociceptive afferents (adapted from Roques et al, 2010 ). (D) Section of the maxillary
branch of the trigeminal nerve of rainbow trout showing the presence of A-delta and C-fibers that may act as
nociceptors (x1000, scale bar = 2 µm; adapted from Sneddon, 20023).

FIGURE 2. The mean time (± SE) rainbow trout (Oncorhynchus mykiss) took to resume feeding after being shamhandled but not injected (control), injected with only saline solution, or only morphine, or only acid or acid plus
13
morphine (*P <.05; modified from Sneddon 2003

MS-222 and Benzocaine
This class of drugs is routinely used in clinical and veterinary medicine as topical analgesics. MS-222
(ethyl 3-aminobenzoate, tricaine methanesulphonate, metacaine) and benzocaine (ethyl 4aminobenzoate) are the 2 most common anesthetic agents used in fish research studies and are also
used in food fish production. Both drugs are approved for aquaculture use in several countries including
the United States and Norway. These local anesthetics inhibit the initiation and propagation of action
22,23
potentials by blocking voltage-sensitive sodium channels.
Administration of MS-222 and benzocaine
is usually via immersion, entering the body via gill uptake and producing anesthesia by impeding neuronal
signal transmission peripherally to the central nervous system. In fish, the precise action of these agents
24-26
is not fully known.
Benzocaine is structurally similar to the chemical composition of MS-222; however,
this agent must first be dissolved in an organic solvent (usually ethanol), whereas MS-222 is soluble in
water but has an acidic pH that requires addition of a buffer (i.e., sodium bicarbonate is usually added to
obtain the desired pH). Dosages of both drugs vary between species. For example, in Atlantic salmon
27
(Salmo salar) MS-222 is administered at 65 mg/L, as is benzocaine, whereas in halibut (Hippoglossus
28
hippoglossus), MS-222 is given at 80 mg/L and benzocaine at 40 mg/L; and in cod (Gadus morhua)
29
MS-222 and benzocaine are administered at 60 mg/L and 25 mg/L, respectively. Increased heart rate
and respiration are observed in the initial phase of anesthesia using these drugs, as well as
30,31
hyperglycemia, and are followed by a depression of heart rate and ventilation.
Side effects include
hypoxemia, hypoglycemia, and increased levels of lactic acid, suggesting a reliance on anaerobic
21,31-36
metabolism, increased hematocrit, and hemoglobin values, as well as erythrocyte swelling.
Plasma
33,37,38
catecholamine values increase in some species, suggesting a possible stress response.
Metomidate
Metomidate hydrochloride (methyl 3-[1-phenylethyl] imidazole-4-carboxylate hydrochloride) is a
nonbarbiturate hypnotic that activates and modulates inhibitory gamma-aminobutyric acid type A
(GABAA) receptors and is a methyl analog of the imidazole derivative etomidate. This anesthetic agent is
39,40
a centrally acting drug.
Metomidate produces sedation and hypnosis in humans, 41 is a clinical and
42,43
44,45
veterinary sedative,
and affects adrenal steroidogenesis inhibiting production of cortisol,
which has

46,47

been observed in fish.
Deleterious effects of metomidate in fish are reduced respiration and
21,30,33
circulation, subsequently leading to hypoxemia and reduced pH of the blood.

TABLE 1. Descriptions of the stages of anesthesia and the parameters used to monitor anesthesia in fish. A number
of procedures are provided as examples of what can be done to the fish under these levels of anesthesia
Level of
Anesthesia

General
Demeanor

Activity

Equilibrium

Gill
Ventilation
Rate

Reactivity

Heart
Rate

Muscle
Tone

0

Normal

Normal

Normal

Normal

Normal

Normal

Normal

Normal

I

Lightly
sedated

Disoriented

Reduced

Normal

Normal

Normal

Normal

II

Excitation

Agitated

Increased

Difficulty

Increased

Increased

Increased

Normal

III

Light
anesthesia

Decreased

Reflex
responses†

Stage

IV

Plane

1

Anesthetized

None

Loss

Regular

Decreased

Weight; close
visual inspection;
external
noninvasive tags,
gill scrape
Invasive tags;
tissue removal;
injection; blood
sampling; gill
biopsy, lesion
dressing, recovery
surgery‡

2

Surgical*

Anesthetized

None

Loss

Shallow

None

Reduced

Decreased

3

Deep

Anesthetized

None

Loss

Rare
movements

None

Reduced

Relaxed

Overdose

Apparently
dead

None

Loss

None

None

Cardiac
failure

None

92

48

93

94

Examples of
Procedures

Non-recovery
surgery‡

19

Adapted from Bell, 1987 ; Burka et al, 1997 ; McFarland, 1959 ; McFarland and Klontz, 1969 ; Summerfelt and Smith, 1990 .
*Some authors suggest there is an intermediate stage between light and surgical termed medium plane anesthesia.
†An example of a reflex response is the fish swimming in response to a tail pinch.
‡Usually accompanied by the use of artificial ventilation where the gills are irrigated with fresh or anesthetic dosed water.

2-Phenoxyethanol
2-Phenoxyethanol is commonly used as a preservative in vaccines, skin products, and perfumes. The
precise mode of action of this anesthetic in fish is unknown, but it may involve an expansion of neuronal
48
cell membranes and, therefore, may suppress activity in the central nervous system. Side effects
include impaired ventilation, reduced cardiovascular responses, lowered blood O2, increased CO2, and
reduced pH, as well as a possible stress response including higher concentrations of plasma adrenaline
33,49
50
and glucose.
2-Phenoxyethanol also reduces immune function of the animal in which it is used.

TABLE 2. Summary of selected anesthetic agents used in fish showing the range of doses, used in a variety of
species and the resultant side effects (see Neiffer and Stamper, 200917 for species-specific information and also the
citations in text)

Anesthetic Agent

Dose
-1
(mg/L )

Side Effects
Initial

Secondary

50-400

Tachycardia
Increased
respiration
Hyperglycemia

Decreased cardiovascular responses
Hypoglycemia
Increased lactate, hematocrit, and catecholamines
Erythrocyte swelling

Benzocaine

25-150

Tachycardia
Increased
respiration
Hyperglycemia

Decreased cardiovascular responses
Hypoglycemia
Increased lactate, hematocrit, and catecholamines
Erythrocyte swelling
Suppressed immune function

Clove 0il

4-150

Decreased ventilation and cardiovascular responses

Eugenol

20-200

Increased catecholamines and hematocrit

Isoeugenol

3.6-120

MS-222

Metomidate

2-Phenoxyethanol

0.06-10

Reduced adrenal steroid production leading to
reduced cortisol
Reduced respiration, circulation, and pH of blood
Hypoxemia

0.25-600

Decreased ventilation rate, heart rate, blood
pressure, and blood pH
Increased adrenal hormones
Hyperglycemia
Reduced immune function

Quinaldine

10-50

Quinaldine sulphate

5-100

Tachycardia

Decreased heart rate and respiratory function
Increased cortisol and serum immunoglobulin M
Hyperglycemia

These doses are not appropriate for all species or under all conditions (e.g., temperature, body size, and
physiological state must be investigated before use). When working with unfamiliar species or agents, use the
lowest doses and low numbers of fish to test anesthetic efficacy.

Isoeugenol
Isoeugenol (2-methoxy-4-prop-1-enyl-phenol), a component of clove oil, is structurally similar to eugenol,
a potent analgesic used in dentistry. This anesthetic agent impedes sodium, potassium, and calcium
51-55
channels, inhibits N-methyl D-aspartate (NMDA) receptors, and potentiates GABA A receptors.
Isoeugenol has become a commonly used fish anesthetic and is the active ingredient in Aqui-S (Aqui-S
New Zealand LTD, Lower Hutt, New Zealand); it is also an approved drug in some countries for use in
aquaculture. Detrimental side effects of isoeugenol include impaired ventilation and depression of the
cardiovascular system, which result in slower heart rate, decreased cardiac output, and reduced blood
21,30
pressure.
Increased plasma catecholamines and increased hematocrit may indicate a stress response
21
elicited by the use of this anesthetic agent.
Quinaldine
The quinoline family of compounds has antiseptic and antipyretic properties and is used in a variety of
preparations, including antimalarial medicines. Quinaldine (2-methylquinoline) has been used to
anesthetize fish for many years, but its mode of action is unknown. Initially, fish display a tachycardia;
56
however, this is soon followed by bradycardia and impaired respiration. Elevated stress responses have
34,50
also been recorded.

FIGURE 3. Mean induction time (s±SE) of Atlantic cod (Gadus morhua) of body size 100 g and 1000 g
anesthetized at 8°C and 16°C with benzocaine (BZ), MS-222 (MS222), metomidate (Met), and 2phenoxyethanol (2-phe) administered individually. Induction time is defined as time from submersion in the
anesthesia bath to total loss of equilibrium. For benzocaine (1000-8C not tested) and MS-222, induction times
were found to increase with increasing body weight but not for metomidate or 2-phenoxyethanol. Induction
rates were shorter at 16°C than at 8°C except for 2-phenoxyethanol in the 1000 g fish (adapted from Zahl et al,
200929).

ADMINISTRATION OF ANESTHETIC AGENTS
Generally, the anesthetic drugs discussed above are administered as a single agent in fish. However, in
veterinary and clinical practice, combining agents with different properties provides a more complete
anesthesia than one single drug alone. Complementary effects between the different agents can result in
safer, lower doses. In some cases, induction and recovery are improved and adverse side effects are
57
reduced. Combination anesthesia has been explored in fish. For example, MS-222 and quinaldine
administered to rainbow trout (Oncorhynchus mykiss) and northern pike (Esox lucius) resulted in less
58
mortality and adverse side effects. Quinaldine used with diazepam (dose range, 0.6-1.2 parts per
million) lowered the dose of both agents when anesthetizing gilthead sea bream (Sparus aurata) and
59,60
European sea bass (Dicentrarchus labrax).
This drug combination also reduced the mortality rate and
59,60
undesirable effects of quinaldine in the 2 fish species in which it was investigated.
MS-222 immersion
anesthesia combined with intraoperative injections of local analgesics has been used during surgical
61
procedures in koi carp (Cyprinus carpio). Administration of butorphanol improved subsequent behavior
and recovery, whereas ketoprofen reduced muscle damage; therefore, their use may be beneficial. This
approach was also effective in Atlantic cod when they were administered a combination of metomidate
29
and either benzocaine or MS-222. Recovery times were much faster with a combination of these agents
than one alone. In halibut, combination anesthesia also allowed the dose of each anesthetic drug used to
be reduced. Improvements in induction and recovery rates were dependent on body size, with smaller
fish having quicker induction times but larger fish exhibiting a much faster recovery rate compared with
28
the use of one agent. Thus, combination anesthesia may be safer because this allows a reduction in
dose, which is generally reflected in better recovery and lower mortality rates along with reduced adverse
side effects in some cases. More experimental studies are needed to develop reliable combination
protocols on a greater variety of fish species.
FACTORS AFFECTING ANESTHESIA
Biological factors such as age, sex, body condition and weight, developmental stage, growth and
physiological status, health, and reproductive condition, as well as abiotic factors such as water quality,
temperature, and oxygenation affect the efficacy of fish anesthesia. In fish, body condition, water
temperature, and physiological stress have been investigated to determine their precise effects on
anesthesia.
Body Condition
Research investigations have focused on body weight because drug dosing is often relative to the weight
of an animal. However, some experimental studies on fish conclude that there is no effect of weight on
62,63
29,47,64
induction and recovery,
whereas others have opposite findings (Fig 3).
Larger body size in
whitefish (Coregonus lavaretus) was found to be associated with decreased induction times; in contrast,
larger-sized rainbow trout had longer induction times and there was no effect in Atlantic salmon or brown
65
trout (Salmo trutta). Induction increased with greater body weight in Senegalese sole (Solea
66
senegalensis) using isoeugenol, 2-phenoxyethanol, and metomidate, but not for MS-222. Yet, MS-222
and benzocaine action were affected by body weight in Atlantic cod; larger fish had longer induction and
29
recovery times (Fig 3). Only recovery was affected by body size when using metomidate in Atlantic cod,
whereas the characteristics of 2-phenoxyethanol anesthesia had no relationship with size. Thus, these
agents appear to have species-specific differences in their action, and research into factors such as lipid
solubility and lipid content of fish is needed to explore the mechanisms of these body weight
relationships.

FIGURE 4. Mean (A) induction and (B) recovery time (s ± SE) in Atlantic halibut (Hippoglossus hippoglossus)
anesthetized with benzocaine (BZ) and MS-222. Induction time is recorded in seconds and is defined as the
time from submersion in the anesthesia bath to total loss of equilibrium. Recovery is defined as time from
transfer to recovery bath to regain of equilibrium. Average body weight of the fish was 1243 g, exposure time
was 5 minutes, and water temperature was 8°C or 15°C. Induction was significantly shorter at the higher
temperature, but recovery was significantly longer (adapted from Zahl et al, 201191).

Water Temperature
Fish are poikilothermic and as such their physiology and metabolic rate are dependent on ambient water
temperature. Studies have explored the impact water temperature has on the efficacy of anesthetic
agents. Higher temperatures often reduce induction and recovery times. For example, isoeugenol in
Atlantic salmon, brown trout, whitefish, perch (Perca fluviatilis), rainbow trout, and roach (Rutilus rutilus);
benzocaine in striped bass (Morone saxatilis); 2-phenoxyethanol and isoeugenol in Atlantic cod, Atlantic
halibut, European sea bass, and gilthead sea bream; and isoeugenol in rainbow trout have shorter

29,63,65-69

induction and recovery rates at higher temperatures.
MS-222 anesthesia is faster at higher
70-72
temperatures in a variety of freshwater and marine fish.
However, there is not a consistent simple
relationship with water temperature relative to induction and recovery. For example, induction was much
quicker in halibut at higher temperatures but recovery was more prolonged (Fig 4). Caution should be
applied in regards to the relationship between water temperature and anesthesia. Furthermore, rapid
changes in water temperature may cause stress to fish and effect their metabolic rate, circulation, and
29
uptake of the anesthetic agent(s).

FIGURE 5. Mean plasma cortisol concentrations (± SE) of sunshine hybrid striped bass (Morone chrysops x M.
saxatilis) exposed to low concentrations of several anesthetic agents for 15 minutes (Aqui-S; Clove oil, Clo;
metomidate, met; MS-222; quinaldine sulfate, QS; quinaldine, Quin.

Physiological Stress
Anesthesia is profoundly affected by stress in fish. Stress results in increased cardiovascular responses
and gill blood flow, producing greater diffusion of immersion anesthetic agents. Therefore, it is vital that
stress is minimized before and during the anesthetic event. As outlined above, many anesthetic drugs
28,46
elicit hormonal stress responses as a side effect (Fig 5).
Acute stress before anesthesia with MS-222
29
in Atlantic cod resulted in shorter induction time and prolonged recovery. A deeper plane of anesthesia
was observed in these fish after an acute stressor such that the dose of MS-222 was reduced to avoid
mortality. However, the benefits of using anesthetic agents during potentially stressful procedures to
render the fish unconscious are important to minimize any negative impacts on their welfare. Several
46,73-78
studies have shown that handling stress is profoundly reduced when fish are anesthetized.
Cortisol
is elevated during handling in Atlantic salmon, but when anesthetized with metomidate, cortisol release is
47
prevented. Therefore, the physiological status of the fish should be evaluated before anesthetizing the
animal so that one can determine the most appropriate agent and dose. Monitoring of heart rate during
prolonged procedures is advisable, especially during invasive surgery because this physiologic parameter
is a direct reflection of the fish’s level of anesthesia (Fig 6).
ANALGESIA IN FISH
In clinical and veterinary practice, analgesic drugs are administered to reduce pain and improve wellbeing, thereby promoting recovery of the patient. Analgesic protocols are available for a variety of
61,79
animals,57,70 but these drugs are generally not administered to fish.
Research on teleost fish

demonstrates that potentially painful events impair their normal behavior and may be indicative of
6-8,10,11,13,80,81
discomfort.
Prolonged changes in behavior have been observed, but relatively few studies
have explored the use of analgesia to reduce these abnormal activities. The major classes of analgesic
drugs are opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), local anesthetics, and miscellaneous
drugs that have pain-relieving properties (e.g., antidepressants). Only the first 3 classes have been
explored as potential pain-relieving drugs in fish (Table 3).

FIGURE 6. An example of a laboratory set up where long-term anesthesia is maintained. Surgically
anesthetized rainbow trout (Oncorhychus mykiss) are placed in a purpose-built cradle, covered with wet
tissues to prevent drying out of the skin, held in place with Velcro straps, and fitted with a purpose-built
mouthpiece and tubing to supply temperature controlled, aerated water. Heart rate is monitored via
electrodes placed under both pectoral fins to gauge level of anesthesia along with reflex responses such as
no response to tail pinch. This is taken from a nonrecovery procedure (photo by Dr P. J. Ashley in the
Sneddon Laboratory).

Opioids
Opioid drugs, typified by morphine, produce analgesia by acting on the 3 opioid receptors (mu, delta, and
kappa) located on neuronal cell membranes. The presynaptic action of opioids inhibits neurotransmitter
release, thereby blocking not only the activity of nociceptors but also centrally blocking transmission.
Morphine administered to rainbow trout ameliorated the effects of a potentially painful stimulus; fish did
not show a suspension in feeding and morphine reduced ventilatory responses and anomalous
13
behaviors, which were exhibited by noxiously treated fish (Fig 2). Noxiously stimulated trout also do not
show a neophobia to novel objects; however, morphine administration to noxiously treated fish resulted in
9
normal fear responses during these tests. Therefore, it was concluded that morphine is an effective
analgesic in rainbow trout. Morphine did not increase the temperature threshold in goldfish (Carassius
auratus) in cases in which the fish performed an escape response to noxious heat but did ameliorate
subsequent adverse changes in behavior of the fish in the tank after temperature threshold testing, which
12
suggests morphine had a possible effect on reducing pain in these fish. Morphine behaves
pharmocokinetically similar in fish compared with mammals; however, excretion rates are much slower
(half-life of 37 hours and total elimination time of 56 hours) and morphine persists for a prolonged period

82,83

after administration.
This suggests that its use is favorable in chronic conditions or after major surgery
because no further doses may be required.

TABLE 3. The analgesic drugs tested in fish showing the range of doses tested, the species of fish that these
were tested on, side effects including whether the analgesic improved pain-related changes, and a comment
on efficiency as an analgesic

Analgesic

Dose

Species

Side Effects

Efficacy

Lidocaine

0.1-2 mg/kg

Trout (IM)
Zebrafish (IM)

None observed

Very efficient at 1 mg/kg

Morphine

5-50 mg/kg

Trout (IM)
Flounder (IP)
Goldfish (IM)

None observed

Very efficient at 5 mg/kg

Buprenorphine

0.01-0.1 mg/kg

Trout (IM)

Reduced activity
No impact on
feeding or ventilation

Not efficient

Carprofen

1-5 mg/kg

Trout (IM)

Depressed activity

Reduced time to feed using
2.5 mg/kg

Increased ventilation

Butorphanol

0.25-5 mg/kg

Ketoprofen

1-4 mg/kg

Dogfish - not efficient
Improved behavior in Koi

Koi carp (0.4; IM)
Dogfish (IM)

Koi carp (2; IM)

No impact on
behavior in Koi

Not efficient

86

82

Dogfish (IM)

13

61

83

Adapted from Sneddon, 2003 ; Harms et al, 2005 ; Davis et al, 2006 ; Newby et al, 2006 ; Newby et al, 2009 ;
14
12
Mettam et al, 2011 ; Nordgreen et al, 2009 ; Sneddon, unpub. data.
Abbreviations: IM, Intramuscularly; IP, Intraperitoneally.

Studies have investigated reflex responses to electric shock using the opioids, tramadol, dermorphine,
and β-casomorphin in cod, steelhead trout (Salmo mykiss), carp, and rainbow trout and have found a
84,85
reduction in the magnitude of the response.
Butorphanol has been explored in the chain dogfish
(Scyliorhinus rotifer) and koi carp as part of a combined anesthetic protocol; however, it appeared to have
61,86
14
limited effectiveness.
Buprenorphine was found to have poor analgesic properties in rainbow trout.
Nonsteroidal Anti-inflammatories The NSAID class of drugs works by inhibiting arachidonate cyclooxygenase (COX) enzymes to reduce the production of thromboxanes and prostaglandins, providing
57,87
antiinflammatory, antipyretic, and analgesic properties.
Very few NSAIDs have been evaluated with
respect to analgesia in fish. Ketoprofen was used in the chain dogfish to determine the minimum

anesthetic concentration of MS-222 to prevent a response to an acute noxious stimulus; however, this
86
approach was not effective. Ketoprofen did reduce the indicators of muscle damage postsurgery in koi
61
carp but did not ameliorate subsequent behavioral changes. Carprofen was investigated in rainbow trout
that exhibited pain and the fish resumed feeding more quickly than fish with no analgesia. However, when
a 5.0 mg/kg carprofen dose was administered to rainbow trout, the fish were found to have depressed
14
activity, even in control fish, and as such may be a deleterious side effect (Table 3). NSAIDs require
further investigation if they are to be recommended as a reliable, effective analgesic in fish. The chronic
use of NSAID analgesic drugs in mammals, birds, and reptiles can result in gastric ulcers or renal
disease, but these effects are currently unknown in fish.
Local Anesthetic Agents
Local anesthetic agents inhibit the propagation of action potentials by blocking sodium channels and by
57,88,89
affecting membrane function.
Therefore, local anesthetic drugs impede pain sensation by blocking
nociceptive transmission. Relatively few studies have explored local anesthetic drugs; however,
90
novocaine is known to reduce reflex responses in cod ; this alone is not considered sufficient evidence to
recommend its use in vivo. Lidocaine has been explored in rainbow trout with substantial success (Table
14
3). Lidocaine at a dose of 1 mg/kg was effective in reducing all of the adverse behavioral and
physiological responses to pain in this species. More research is necessary to test the wide range of local
anesthetic agents on a range of fish species to construct reliable analgesic protocols.
CONCLUSION
A variety of anesthetic drugs have been investigated for their properties to provide effective anesthesia of
fish. However, given the significant diversity of fish species and their associated environmental and
physiological requirements, it would be prudent to apply caution when selecting an anesthetic agent.
Tentative exploration of the correct dose is vital because many factors influence anesthetic action
including body size, water temperature, and physiological status. Combination anesthesia requires more
attention given the positive findings from a number of studies that demonstrate reduced mortality rates
and lower doses, which also appears to result in reduced side effects and better recovery. Humane
treatment of fish subject to tissue-damaging, invasive procedures demands that any pain and discomfort
are reduced by the use of an analgesic agent. However, the development of robust, valid analgesic
protocols requires further study given the limited number of scientific studies. Currently, only morphine
and lidocaine can be recommended in one species, the rainbow trout. Therefore, analgesic drugs need to
be investigated in a range of species to determine their applicability in a variety of patient conditions; this
8,79
will also require the development of pain indicators specific to the pain type and fish species.
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